View all cases
- Case details
- Status—ActionRevocationCategoryMain revocation action
- Parties
- Claimants
- ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINEOperating co.
Representatives- Not named-Potter Clarkson
Respondents- Healios K.KOperating co.
- Osaka UniversityUniversity / research
- Division
- Paris CD
- Judges
- —
- Technology
- ChemistryBiotechnology · Pharmaceuticals
- Language
- —
- First decided
- Jun 16, 2023
- EPO Opposition
- STRAWMAN LIMITED2022-04-20
How this compares
The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.
| Patent revoked | Median days to first decision | |
|---|---|---|
| All UPC | 37% (34/91) | 124 |
| Paris CD | Locked | Locked |
At the UPC: ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE (4 cases)·Healios K.K (4 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 3 other proceedings
Decisions
- 2023-06-16Revocation ActionPublic
Summary: The Central Division (Paris) ordered redistribution of Astellas Institute's revocation action against Healios K.K. and Osaka University concerning EP 3 056 564 B1 to the Munich Section under Rule 17.3 RoP.
Show the legal issues (3)
- Distribution of cases Rule 17.3 RoP
- Central Division sections
- Revocation action
Documents
- 23-06-16-cd-paris-order-redistribution-munich-section-upc_cfi_80_2023-anonymized.pdf2023-06-16EN